Hiroshi Masumoto

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Koichiro Ogata, Jeanne Mendell‐Harary, Masaya Tachibana et al. · The Journal of Clinical Pharmacology · 2010 · 446 citations

Pharmacological Study, Medicine, Clinical Safety +10

Construction of YAC–based mammalian artificial chromosomes

Masashi Ikeno, Brenda R. Grimes, Tuneko Okazaki et al. · Nature Biotechnology · 1998 · 419 citations

Genetics, Genetic Engineering, Chromosome Biology +2

Pharmacokinetics, Biotransformation, and Mass Balance of Edoxaban, a Selective, Direct Factor Xa Inhibitor, in Humans

Mohinder S. Bathala, Hiroshi Masumoto, Toshihiro Oguma et al. · Drug Metabolism and Disposition · 2012 · 188 citations

Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case–control study

Koji Hirata, Hitoshi Takagi, Masaru Yamamoto et al. · The Pharmacogenomics Journal · 2007 · 181 citations

Inflammation, Autoimmune Disease, Hepatology +13

The Reaction of Ebselen with Peroxynitrite

Hiroshi Masumoto, Helmut Sies · Chemical Research in Toxicology · 1996 · 168 citations